BEIJING PROTGEN LTD has a total of 17 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2007. It filed its patents most often in Australia, China and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are TURECEK PETER, JEFFERIES WILFRED and SICHUAN HUIYU PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | China | 3 | |
#3 | Canada | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Analysing materials | |
#7 | Microorganisms | |
#8 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Chang Guodong | 15 |
#2 | Luo Yongzhang | 10 |
#3 | Zhou Daifu | 8 |
#4 | Li Hui | 7 |
#5 | Wang Wenchao | 7 |
#6 | Fu Yan | 6 |
#7 | Jia Lin | 5 |
#8 | Chen Yang | 3 |
#9 | Lu Xinan | 3 |
#10 | Liu Peng | 2 |
Publication | Filing date | Title |
---|---|---|
WO2018086603A1 | Pegylated endostatin analogue and application thereof | |
WO2017190671A1 | Construction of engineering bacteria for high expression of recombinant human serum albumin | |
CN101219219A | Complex containing vascellum chalone or fragment, preparation method and application thereof |